Upload Avatar (500 x 500)
Jing Huang
huangjing82@bjmu.edu.cn
Chinese, English
Beijing
Peking University
Basic Medical Sciences
  • 2003-2008 Doctor of Medicine in Immunology: Peking University
  • 1998-2003 Bachelor of Medicine in Nursing: Peking University
  • 2012.8-present Associate Professor, Department of Immunology, Peking University
  • 2014.1-2015.3 Visiting Scholar, Dana-Farber Cancer Institute, Harvard Medical School, USA
  • 2008.8-2012.7 Lecturer, Department of Immunology, Peking University
Tumor immunology and immunotherapy
  • Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection, J Huang, 2022
  • Macrophage-derived immunoglobulin M inhibits inflammatory responses via modulating endoplasmic reticulum stress, J Huang, 2021
  • Ccdc134 deficiency impairs cerebellar development and motor coordination, J Huang, 2021
  • Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients, J Huang, 2021
  • Hepatocyte-derived Igκ exerts a protective effect against ConA-induced acute liver injury, J Huang, 2020
  • CCDC134 Ameliorated Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 cells, J Huang, 2018
  • The Potential Predictive Value of Circulating Immune Cell Ratio and Tumor Marker in Atezolizumab Treated Advanced Non-Small Cell Lung Cancer Patients, J Huang, 2018
  • CCDC134 plays a crucial role in embryonic development, J Huang, 2018
  • Amelioration of adjuvant-induced arthritis in CCDC134-overexpressing transgenic mice, J Huang, 2017
  • The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1-/- murine model of ovarian cancer, J Huang, 2015
  • Cytokine-like molecule CCDC134 Contributes to CD8+ T-cell effector functions in cancer immunotherapy, J Huang, 2014
  • Rearrangement and expression of immunoglobulin μ chain gene in human myeloid cells, J Huang, 2014
Tumor Immunology Immunotherapy Cellular Molecular Mechanism Ccdc134 Ig Interdisciplinary Clinical

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.